Source:http://linkedlifedata.com/resource/pubmed/id/15057783
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
4
|
| pubmed:dateCreated |
2004-4-1
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Apr
|
| pubmed:issn |
1474-1733
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
4
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
249-58
|
| pubmed:dateRevised |
2005-11-16
|
| pubmed:meshHeading |
pubmed-meshheading:15057783-Animals,
pubmed-meshheading:15057783-Antigens, Bacterial,
pubmed-meshheading:15057783-CpG Islands,
pubmed-meshheading:15057783-Humans,
pubmed-meshheading:15057783-Immunotherapy,
pubmed-meshheading:15057783-Oligodeoxyribonucleotides,
pubmed-meshheading:15057783-Signal Transduction
|
| pubmed:year |
2004
|
| pubmed:articleTitle |
Immunotherapeutic uses of CpG oligodeoxynucleotides.
|
| pubmed:affiliation |
CBER/FDA, Bethesda, Maryland 20892, USA. klinman@cber.FDA.gov
|
| pubmed:publicationType |
Journal Article,
Review
|